Editorial Standards and Medical Review Process

This page outlines how we research, write, review, and correct material on Retatrutide-Peptide.biz. Because we cover a drug that is still under investigation, the evidence base is continually evolving, and much online information consists of personal anecdotes or promotional content. These are the standards we uphold.

Information sources

Facts are sourced from references in this order of preference:

1. Peer-reviewed trial publications the primary reports from the retatrutide clinical trials.
2. Trial registries ClinicalTrials.gov entries for trial design, dosage arms, and status.
3. Regulators the FDA for approval status, compounding regulations, and safety alerts.
4. Government health bodies NIH, NIDDK, and other reputable institutions for background physiology.

We do not treat forum posts, vendor pages, influencer videos, or AI summaries as factual sources. When we describe anecdotal reports, as on our reviews pagewe clearly label such content as anecdote and note that it is unverified.

Our approach to discussing an investigational drug

• All pages clearly state that retatrutide is not FDA-approved.
• Trial data are explicitly attributed to the relevant trial, including phase and dose, and are never presented as typical outcomes.
• We deliberately use cautious language such as 'may,' 'in trials,' and 'as reported.' We never promise outcomes.
• We do not publish dosing schedules, administration guidance, or personal use instructions. The products we offer are intended for laboratory research only.
• We do not share before-and-after images, named testimonials, or any visuals that suggest proof of results.

Medical review

Science pages are reviewed before publication and are rechecked whenever evidence or regulatory status changes. A review confirms that the content matches cited sources, uses appropriate hedging, and contains nothing that could be taken as personalized medical advice or directions for human consumption. Reviews are not endorsements of any product or vendor, and reviewers are not involved in sales.

Reviewed pages show the reviewer's name, credentials, and review date. Reviewers are identified on our authors and reviewers page.

Review schedule

Independence and advertising

We earn revenue when customers purchase research-grade materials from our store, as described on our about pageWe do not sell guest posts, nor do we accept payments to endorse specific vendors or labs, and no outside parties preview our content before release.

Corrections

When we make an error, we correct it openly and clearly. Substantive changes are flagged at the bottom of the page with the date and a brief note; typos and minor fixes are made without comment. To alert us to a mistake, email editorial@retatrutide-peptide.biz covering the page URL as well as, where available, a source citation.

Use of AI

We use AI tools to assist with drafting and layout. Prior to publication, a human editor examines the content and checks it against the primary references listed above. On scientific subjects, machine-generated text is never released without this kind of editorial review.